P71 Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one centre’s experience | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Respiratory medicine: common problems, new insights

P71 Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one centre’s experience

Free

Online download statistics by month:

Online download statistics by month: November 2017 to August 2024

	Abstract	Full	Pdf
Nov 2017	98	0	8
Dec 2017	34	0	3
Jan 2018	70	0	6
Feb 2018	32	0	1
Mar 2018	16	0	0
Apr 2018	42	0	2
May 2018	62	0	5
Jun 2018	24	0	1
Jul 2018	22	0	0
Aug 2018	18	0	3
Sep 2018	20	0	1
Oct 2018	28	0	2
Nov 2018	42	0	9
Dec 2018	20	0	3
Jan 2019	40	0	1
Feb 2019	28	0	3
Mar 2019	28	0	4
Apr 2019	30	0	9
May 2019	12	0	8
Jun 2019	26	0	5
Jul 2019	16	0	4
Aug 2019	30	0	2
Sep 2019	22	0	5
Oct 2019	6	0	0
Nov 2019	18	0	2
Dec 2019	14	0	2
Jan 2020	8	0	0
Feb 2020	2	0	1
Mar 2020	2	0	1
May 2020	4	0	1
Jun 2020	0	0	1
Jul 2020	12	0	3
Aug 2020	1	0	1
Sep 2020	15	0	1
Oct 2020	12	0	7
Nov 2020	9	0	0
Dec 2020	23	0	12
Jan 2021	6	0	3
Feb 2021	4	0	10
Mar 2021	10	0	3
Apr 2021	8	0	7
May 2021	4	0	7
Jun 2021	0	0	4
Aug 2021	0	0	3
Sep 2021	0	0	5
Oct 2021	6	0	12
Nov 2021	0	0	7
Dec 2021	12	0	2
Jan 2022	12	0	3
Feb 2022	4	0	0
Mar 2022	6	0	1
Apr 2022	4	0	1
May 2022	49	0	14
Jun 2022	8	0	2
Jul 2022	6	0	1
Aug 2022	7	0	2
Sep 2022	2	0	5
Oct 2022	3	0	2
Nov 2022	12	0	6
Dec 2022	10	0	1
Jan 2023	11	0	6
Feb 2023	2	0	0
Mar 2023	14	0	0
May 2023	3	0	1
Jun 2023	6	0	5
Jul 2023	4	0	8
Aug 2023	0	0	4
Sep 2023	7	0	9
Oct 2023	2	0	9
Nov 2023	7	0	5
Dec 2023	12	0	1
Jan 2024	10	0	1
Feb 2024	8	0	1
Mar 2024	2	0	19
Apr 2024	17	0	16
May 2024	6	0	2
Jun 2024	0	0	1
Jul 2024	6	0	4
Aug 2024	20	0	1
Total	1196	0	311